Unusual Options Activity: ET, MAT and Others Attract Market Bets, ET V/OI Ratio Reaches 344.8
SA Analyst Upgrades: AMD, MPW, LYV, TGTX
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (AXSM), TG Therapeutics (TGTX) and Vertex Pharmaceuticals (VRTX)
BofA Securities Maintains TG Therapeutics(TGTX.US) With Sell Rating, Maintains Target Price $11
TG Therapeutics First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
Sell Rating for TG Therapeutics Amidst Growth Concerns and Competitive Challenges
